EHA 2026 | What are the key findings from the DALY 2-EU trial of zamto-cel in R/R LBCL?
The Lymphoma Hub was pleased to speak with Gloria Iacoboni, Vall d'Hebron University Hospital, Barcelona, ES. We asked, What are the key findings from the DALY 2-EU trial of zamtocabtagene autoleucel (zamto-cel) in relapsed/refractory (R/R) large B-cell lymphoma (LBCL)? This educational resource is independently supported by Miltenyi Biomedicine. All content is developed by SES in collaboration with an expert steering committee. Funders are allowed no influence.
▶︎
EHA 2026 | What are the key findings from the phase I ANTLER trial in R/R B-cell NHL?
▶︎
Eat THIS the Night Before CHEMO (Side Effect FREE!)
▶︎
EHA 2026 | Recent findings from the phase I NX-5948-301 trial of bexobrutideg in CLL
▶︎
Zanubrutinib for patients with previously untreated CLL/SLL: Insights from the SEQUOIA trial
▶︎
ASH 2025 | Key highlights in lymphoma and CLL
▶︎
The French Do Not Care About Work
▶︎
It's NOT Memory - 5 Early Dementia Signs Everyone Misses
▶︎
Colin Farrell Opens Up About His Son With Angelman Syndrome | PEOPLE
▶︎
Steve Miller Asks if I Know Fleetwood Mac and This Waitress Steals The Show
▶︎
Posture, Bone Density & Muscle: A Stanford Doctor Destroys Aging Myths Most People Believe
▶︎
Annual oncology meeting | Key highlights in lymphoma
▶︎
The Frank Zappa Interview That Still Feels Dangerous Today (1984)
▶︎
The easiest way to make the world smarter
▶︎
Henry VIII's 'Reject Queen': The Truth About Anne Of Cleves
▶︎
Roger Penrose and Brian Cox discuss 'remarkable new evidence' about the origins of the universe
▶︎
300 Secret Historical Photos You Were Never Supposed to See
▶︎
Use These 5 Food Hacks To Heal The Body & STARVE CANCER I Dr. William Li
▶︎
Typical Soviet Apartment Tour (How Russian People REALLY Live)
▶︎
When Animals Surprise Photographers in the Sweetest Way! 😍
▶︎